Ypsomed Holding AG (YPSN.SW)
Ypsomed Holding AG, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
390.80-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-0.4%
The outlook
Ypsomed Holding AG currently reads as bullish based on buy — 1.8 avg of 13 analysts, above its 50- & 200-day averages, 82% of the way from its 52-week low to high, avg target +0% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 13 analysts
Price trendAbove its 50- & 200-day averages
52-week range82% of the way from its 52-week low to high
Price targetAvg target +0% vs current price
Analyst price target
~12-month · 13 analysts391.15average target+0.1% vs now
Now 390.80
Low 280.00High 455.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.14B
52-wk high
419.50
52-wk low
260.50
50-day avg
359.18
200-day avg
318.95
Trailing P/E
24.0